Extracorporeal membrane oxygenator (ECMO) is effective for maintaining oxygenation and hemodynamic support in patients with post-cardiotomy cardiogenic shock (PCCS). Researchers, led by Ahmed Abdeljawad, sought to compare the effect of early ECMO implantation in emergency patients versus elective patients who developed univentricular or biventricular pump failure. After their trial, they suggested that “early use of ECMO in high-risk emergency cardiac surgery should be taken into consideration when possible, without hesitance.”